A previous study showed that the positive outcome of PD-1 blockade on treating leukemia may be because that it induces significant upregulation of the potent pro-inflammatory and anti-tumor cytokine IFN-γ in certain types of γδ T cells61. This evidence concerns the gene IFNG and leukemia.